Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 8 (2011), Issue 5 (May)

1. Rheumatoid meningitis mimicking progressive supranuclear palsy.
   Neurologist, 17(3): 136-40. [Abstract] [Full-text]
2. Induction of immune tolerance in the treatment of rheumatoid arthritis.
   Nat Rev Rheumatol, 7(5): 272-81. [Abstract] [Full-text]
3. Ex vivo soft-laser treatment inhibits the synovial expression of vimentin and α-enolase, potential autoantigens in rheumatoid arthritis.
   Phys Ther, 91(5): 665-74. [Abstract] [Full-text]
4. Autosome-wide copy number variation association analysis for rheumatoid arthritis using the WTCCC high-density SNP genotype data.
   J Rheumatol, 38(5): 797-801. [Abstract] [Full-text]
5. Classification of odontoid destruction in patients with rheumatoid arthritis using reconstructed computed tomography: reference to vertical migration.
   J Rheumatol, 38(5): 863-7. [Abstract] [Full-text]
6. Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis.
   J Rheumatol, 38(5): 802-9. [Abstract] [Full-text]
7. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide.
   J Rheumatol, 38(5): 828-34. [Abstract] [Full-text]
8. Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis.
   J Rheumatol, 38(5): 821-7. [Abstract] [Full-text]
9. A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report.
   J Rheumatol, 38(5): 938-53. [Abstract] [Full-text]
10. Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation.
    J Leukoc Biol, 89(5): 721-7. [Abstract] [Full-text]
11. Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis.
    J Rheumatol, 38(5): 810-20. [Abstract] [Full-text]
12. Clinical consequences of delayed addition of adalimumab to methotrexate therapy over 5 years in patients with rheumatoid arthritis.
    J Rheumatol, 38(5): 855-62. [Abstract] [Full-text]
13. Predictors of hip disease in the systemic arthritis subtype of juvenile idiopathic arthritis.
    J Rheumatol, 38(5): 954-8. [Abstract] [Full-text]
14. Evaluation of an inter-professional educational intervention to improve the use of arthritis best practices in primary care.
    J Rheumatol, 38(5): 931-7. [Abstract] [Full-text]
15. A 24-week, randomized, double-blind, placebo-controlled, parallel group study of the efficacy of oral SCIO-469, a p38 mitogen-activated protein kinase inhibitor, in patients with active rheumatoid arthritis.
    J Rheumatol, 38(5): 846-54. [Abstract] [Full-text]
16. Sexual dimorphism of RA manifestations: genes, hormones and behavior.
    Nat Rev Rheumatol, 7(5): 307-10. [Abstract] [Full-text]
17. Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis.
    J Rheumatol, 38(5): 835-45. [Abstract] [Full-text]
18. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties.
    Scand J Rheumatol, 40(3): 221-4. [Abstract] [Full-text]
19. Ultrasonography shows significant improvement in wrist and ankle tenosynovitis in rheumatoid arthritis patients treated with adalimumab.
    Scand J Rheumatol, 40(3): 178-82. [Abstract] [Full-text]
20. Treatment with low-dose prednisolone is associated with altered body composition but no difference in bone mineral density in rheumatoid arthritis patients: a controlled cross-sectional study.
    Scand J Rheumatol, 40(3): 161-8. [Abstract] [Full-text]
21. Gustatory and olfactory function in rheumatoid arthritis.
    Scand J Rheumatol, 40(3): 169-77. [Abstract] [Full-text]
22. Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis.
    Scand J Rheumatol, 40(3): 192-6. [Abstract] [Full-text]
23. Epitrochlear and axillary lymph node visualization on FDG-PET/CT imaging in a patient with rheumatoid arthritis.
    Rev Esp Med Nucl, 30(3): 168-70. [Abstract] [Full-text]
24. Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis.
    Arthritis Rheum, 63(5): 1452-8. [Abstract] [Full-text]
25. Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
    Arthritis Rheum, 63(5): 1237-45. [Abstract] [Full-text]
26. A detailed comparative study of high-resolution ultrasound and micro-computed tomography for detection of arthritic bone erosions.
    Arthritis Rheum, 63(5): 1231-6. [Abstract] [Full-text]
27. Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?
    Arthritis Rheum, 63(5): 1190-9. [Abstract] [Full-text]
28. Variation in use of Internet-based patient portals by parents of children with chronic disease.
    Arch Pediatr Adolesc Med, 165(5): 405-11. [Abstract] [Full-text]
29. Expression of CD64 on polymorphonuclear neutrophils in patients with familial Mediterranean fever.
    Clin Exp Immunol, 164(3): 365-72. [Abstract] [Full-text]
30. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies.
    Clin Exp Immunol, 164(3): 337-45. [Abstract] [Full-text]
31. Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium.
    Arthritis Rheum, 63(5): 1246-54. [Abstract] [Full-text]
32. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome.
    Arthritis Rheum, 63(5): 1426-34. [Abstract] [Full-text]
33. Identification of CXCL13 as a marker for rheumatoid arthritis outcome using an in silico model of the rheumatic joint.
    Arthritis Rheum, 63(5): 1265-73. [Abstract] [Full-text]
34. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis.
    Arthritis Rheum, 63(5): 1211-20. [Abstract] [Full-text]
35. The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy.
    Arthritis Rheum, 63(5): 1200-10. [Abstract] [Full-text]
36. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
    Arthritis Rheum, 63(5): 1312-21. [Abstract] [Full-text]
37. In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment.
    Arthritis Rheum, 63(5): 1255-64. [Abstract] [Full-text]
38. Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis.
    Arthritis Rheum, 63(5): 1221-30. [Abstract] [Full-text]
39. Exploring the differential diagnosis of joint complaints in pediatric patients with inflammatory bowel disease.
    Curr Gastroenterol Rep, 13(3): 271-8. [Abstract] [Full-text]
40. Self-management of fatigue in rheumatoid arthritis: a randomised controlled trial of group cognitive-behavioural therapy.
    Ann Rheum Dis, 70(6): 1060-7. [Abstract] [Full-text]
41. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative.
    Ann Rheum Dis, 70(6): 935-42. [Abstract] [Full-text]
42. Treating rheumatoid arthritis to target: the patient version of the international recommendations.
    Ann Rheum Dis, 70(6): 891-5. [Abstract] [Full-text]
43. Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.
    Ann Rheum Dis, 70(6): 1153-9. [Abstract] [Full-text]
44. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.
    Ann Rheum Dis, 70(6): 1039-46. [Abstract] [Full-text]
45. Vitamin D receptor regulates TNF-mediated arthritis.
    Ann Rheum Dis, 70(6): 1122-9. [Abstract] [Full-text]
46. Certolizumab pegol plus methotrexate provides broad relief from the burden of rheumatoid arthritis: analysis of patient-reported outcomes from the RAPID 2 trial.
    Ann Rheum Dis, 70(6): 996-1002. [Abstract] [Full-text]
47. Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level.
    Ann Rheum Dis, 70(6): 1111-4. [Abstract] [Full-text]
48. Early clinical response to treatment predicts 5-year outcome in RA patients: follow-up results from the CAMERA study.
    Ann Rheum Dis, 70(6): 1099-103. [Abstract] [Full-text]
49. Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins.
    Ann Rheum Dis, 70(6): 1052-9. [Abstract] [Full-text]
50. How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
    Ann Rheum Dis, 70(6): 1010-5. [Abstract] [Full-text]
51. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis.
    Ann Rheum Dis, 70(6): 1025-32. [Abstract] [Full-text]
52. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study.
    Ann Rheum Dis, 70(6): 929-34. [Abstract] [Full-text]
53. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis.
    Ann Rheum Dis, 70(6): 1080-2. [Abstract] [Full-text]
54. Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study.
    Ann Rheum Dis, 70(6): 1020-4. [Abstract] [Full-text]
55. Reporting of long-term extension studies: lack of consistency calls for consensus.
    Ann Rheum Dis, 70(6): 886-90. [Abstract] [Full-text]
56. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.
    Ann Rheum Dis, 70(6): 909-20. [Abstract] [Full-text]
57. Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study.
    Ann Rheum Dis, 70(6): 990-5. [Abstract] [Full-text]
58. Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis.
    Ann Rheum Dis, 70(6): 1095-8. [Abstract] [Full-text]
59. Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab.
    Ann Rheum Dis, 70(6): 1160-2. [Abstract] [Full-text]
60. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.
    Ann Rheum Dis, 70(6): 968-72. [Abstract] [Full-text]
61. Phosphodiesterase 4 (PDE4) regulation of proinflammatory cytokine and chemokine release from rheumatoid synovial membrane.
    Ann Rheum Dis, 70(6): 1130-7. [Abstract] [Full-text]
62. Performance of the 2010 ACR/EULAR criteria for rheumatoid arthritis: comparison with 1987 ACR criteria in a very early synovitis cohort.
    Ann Rheum Dis, 70(6): 949-55. [Abstract] [Full-text]
63. The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study.
    Ann Rheum Dis, 70(6): 956-60. [Abstract] [Full-text]
64. High mobility group box 1 induces synoviocyte proliferation in rheumatoid arthritis by activating the signal transducer and activator transcription signal pathway.
    Clin Exp Med, 11(2): 65-74. [Abstract] [Full-text]
65. Cyclic mechanical stretch downregulates IL-1β-induced COX-2 expression and PGE(2) production in rheumatoid arthritis fibroblast-like synoviocytes.
    Connect Tissue Res, 52(3): 190-7. [Abstract] [Full-text]
66. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.
    Atherosclerosis, 216(1): 125-30. [Abstract] [Full-text]
67. Shifting normalities: interactions of changing conceptions of a normal life and the normalisation of symptoms in rheumatoid arthritis.
    Sociol Health Illn, 33(4): 618-33. [Abstract] [Full-text]
68. Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review.
    Joint Bone Spine, 78(3): 279-84. [Abstract] [Full-text]
69. Cell and cytokine imbalances in rheumatoid synovitis.
    Joint Bone Spine, 78(3): 230-4. [Abstract] [Full-text]
70. Evaluation of immune response to hepatitis A vaccination and vaccine safety in juvenile idiopathic arthritis.
    J Chin Med Assoc, 74(5): 205-8. [Abstract] [Full-text]
71. Synthesis and biological evaluation of unique stereodimers of sinomenine analogues as potential inhibitors of NO production.
    Bioorg Med Chem, 19(10): 3096-104. [Abstract] [Full-text]
72. The effectiveness of nurse-led care in people with rheumatoid arthritis: a systematic review.
    Int J Nurs Stud, 48(5): 642-54. [Abstract] [Full-text]
73. Integrated population pharmacokinetics of etanercept in healthy subjects and in patients with rheumatoid arthritis and ankylosing spondylitis.
    J Clin Pharmacol, 51(6): 864-75. [Abstract] [Full-text]
74. Patterns of medication use during pregnancy in rheumatoid arthritis.
    Arthritis Care Res (Hoboken), 63(5): 721-8. [Abstract] [Full-text]
75. Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate.
    Arthritis Care Res (Hoboken), 63(5): 711-20. [Abstract] [Full-text]
76. Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis.
    Arthritis Care Res (Hoboken), 63(5): 675-88. [Abstract] [Full-text]
77. Biologics in rheumatoid arthritis--recommendations for Swiss practice.
    Swiss Med Wkly, 141: w13189. [Abstract] [Full-text]
78. Measuring time input loss among patients with rheumatoid arthritis: validity and reliability of the Valuation of Lost Productivity questionnaire.
    J Occup Environ Med, 53(5): 530-6. [Abstract] [Full-text]
79. Inhibition of IL6 in rheumatoid arthritis and juvenile idiopathic arthritis.
    Exp Cell Res, 317(9): 1286-92. [Abstract] [Full-text]
80. Pre-existing periodontitis exacerbates experimental arthritis in a mouse model.
    J Clin Periodontol, 38(6): 532-41. [Abstract] [Full-text]
81. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease.
    Arthritis Care Res (Hoboken), 63(5): 729-34. [Abstract] [Full-text]
82. Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus.
    Lupus, 20(6): 607-13. [Abstract] [Full-text]
83. 'I start my day by thinking about what we're going to have for dinner'--a qualitative study on approaches to food-related activities among elderly men with somatic diseases.
    Scand J Caring Sci, 25(2): 227-34. [Abstract] [Full-text]
84. Development and psychometric properties of a joint protection self-efficacy scale.
    Scand J Occup Ther, 18(2): 143-52. [Abstract] [Full-text]
85. Management of the radial head and linked total elbow arthroplasty.
    J Shoulder Elbow Surg, 20(4): 625-30. [Abstract] [Full-text]
86. The new criteria for classification of rheumatoid arthritis: what we need to know for clinical practice.
    Eur J Intern Med, 22(3): 217-9. [Abstract] [Full-text]
87. Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 111(6): 673-80. [Abstract] [Full-text]
88. Single nucleotide polymorphisms at the TRAF1/C5 locus are associated with rheumatoid arthritis in a Han Chinese population.
    BMC Med Genet, 12: 53. [Abstract] [Full-text]
89. Fertility in women with chronic inflammatory arthritides.
    Rheumatology (Oxford), 50(6): 1162-7. [Abstract] [Full-text]
90. Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis.
    Rheumatology (Oxford), 50(6): 1137-47. [Abstract] [Full-text]
91. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
    Rheumatology (Oxford), 50(6): 1148-52. [Abstract] [Full-text]
92. An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register.
    Rheumatology (Oxford), 50(6): 1131-6. [Abstract] [Full-text]
93. A double-blind, randomized, placebo-controlled study to explore the efficacy of a dietary plant-derived polysaccharide supplement in patients with rheumatoid arthritis.
    Rheumatology (Oxford), 50(6): 1111-9. [Abstract] [Full-text]
94. Inter-observer reliability of ultrasound detection of tendon abnormalities at the wrist and ankle in patients with rheumatoid arthritis.
    Rheumatology (Oxford), 50(6): 1120-4. [Abstract] [Full-text]
95. The long-term impact of early treatment of rheumatoid arthritis on radiographic progression: a population-based cohort study.
    Rheumatology (Oxford), 50(6): 1106-10. [Abstract] [Full-text]
96. Quantifying the economic burden of productivity loss in rheumatoid arthritis.
    Rheumatology (Oxford), 50(6): 1083-90. [Abstract] [Full-text]
97. Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.
    Rheumatology (Oxford), 50(6): 1070-82. [Abstract] [Full-text]
98. No clear advantage to use of wound drains after unilateral total knee arthroplasty: a prospective randomized, controlled trial.
    J Arthroplasty, 26(4): 519-22. [Abstract] [Full-text]
99. Five- to eight-year results of a prospective study in 118 arthroplasties using posterior-stabilized rotating-platform knee implants.
    J Arthroplasty, 26(4): 543-8. [Abstract] [Full-text]
100. Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent.
     PLoS One, 6(5): e19962. [Abstract] [Full-text]
101. Five to ten-year outcomes of the Universal total wrist arthroplasty in patients with rheumatoid arthritis.
     J Bone Joint Surg Am, 93(10): 914-9. [Abstract] [Full-text]
102. Two-year outcome of partial lacrimal punctal occlusion in the management of dry eye related to Sjögren syndrome.
     Curr Eye Res, 36(6): 507-12. [Abstract] [Full-text]
103. Changes of aquaporins in the lacrimal glands of a rabbit model of Sjögren's syndrome.
     Curr Eye Res, 36(6): 571-8. [Abstract] [Full-text]
104. Bilateral pars fractures complicating long fusion to L5 in a patient with rheumatoid arthritis.
     Spine (Phila Pa 1976), 36(13): E882-5. [Abstract] [Full-text]
105. Posterior interosseous nerve palsy: an unusual complication of rheumatoid arthritis: case report and review of the literature.
     Semin Arthritis Rheum, 40(6): 576-9. [Abstract] [Full-text]
106. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's Syndrome: a retrospective analysis of 65 patients in the Netherlands.
     Semin Arthritis Rheum, 40(6): 547-51. [Abstract] [Full-text]
107. Tacrolimus-induced pulmonary injury in rheumatoid arthritis patients.
     Pulm Pharmacol Ther, 24(4): 401-6. [Abstract] [Full-text]
108. PubMed had a higher sensitivity than Ovid-MEDLINE in the search for systematic reviews.
     J Clin Epidemiol, 64(7): 805-7. [Abstract] [Full-text]
109. When to initiate and discontinue biologic treatments for rheumatoid arthritis?
     J Intern Med, 269(6): 614-25. [Abstract] [Full-text]
110. Necrotizing group A streptococcal periorbital infection following adalimumab therapy for rheumatoid arthritis.
     Cutan Ocul Toxicol, 30(2): 160-2. [Abstract] [Full-text]
111. miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization.
     PLoS One, 6(5): e19827. [Abstract] [Full-text]
112. Average 10.1-year follow-up of cementless total knee arthroplasty in patients with rheumatoid arthritis.
     Can J Surg, 54(3): 179-84. [Abstract] [Full-text]
113. Lower extremity ulcers in rheumatoid arthritis: features and response to immunosuppression.
     Clin Rheumatol, 30(6): 849-53. [Abstract] [Full-text]
114. De novo 19q13.42 duplications involving NLRP gene cluster in a patient with systemic-onset juvenile idiopathic arthritis.
     J Hum Genet, 56(5): 343-7. [Abstract] [Full-text]
115. Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature.
     Rheumatol Int, 31(6): 715-9. [Abstract] [Full-text]
116. Assessment of cervical pain and function in patients with rheumatoid arthritis.
     Clin Rheumatol, 30(6): 831-6. [Abstract] [Full-text]
117. Demographic, clinical, and serological features of Turkish patients with rheumatoid arthritis: evaluation of 165 patients.
     Clin Rheumatol, 30(6): 843-7. [Abstract] [Full-text]
118. Visfatin levels and intima-media thicknesses in rheumatic diseases.
     Clin Rheumatol, 30(6): 757-63. [Abstract] [Full-text]
119. Can simple ultrasonography predict the clinical effect of intra-articular injection therapy of the knee joint?
     Clin Rheumatol, 30(6): 749-55. [Abstract] [Full-text]
120. Arthritic presentation of childhood malignancy: beware of normal blood counts.
     Rheumatol Int, 31(6): 827-9. [Abstract] [Full-text]
121. Disability of Arm Shoulder and Hand Questionnaire in rheumatoid arthritis patients: relationship with disease activity, HAQ, SF-36.
     Rheumatol Int, 31(6): 823-6. [Abstract] [Full-text]
122. Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis.
     Rheumatol Int, 31(6): 785-94. [Abstract] [Full-text]
123. Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status.
     Rheumatol Int, 31(6): 769-72. [Abstract] [Full-text]
124. Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review.
     Rheumatol Int, 31(6): 749-56. [Abstract] [Full-text]
125. Rheumatoid arthritis in patient with homozygous haemoglobin C disease.
     Rheumatol Int, 31(6): 801-3. [Abstract] [Full-text]
126. Physical activity coaching of patients with rheumatoid arthritis in everyday practice: a long-term follow-up.
     Musculoskeletal Care, 9(2): 75-85. [Abstract] [Full-text]
127. The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: a questionnaire-based study of general practitioners.
     Musculoskeletal Care, 9(2): 69-74. [Abstract] [Full-text]
128. Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis.
     Swiss Med Wkly, 141: w13211. [Abstract] [Full-text]
129. Spontaneous bilateral distal ulna fracture: an unusual complication in a rheumatoid patient.
     J Orthop Traumatol, 12(2): 119-22. [Abstract] [Full-text]
130. Increased serum levels of β₂-GPI-Lp(a) complexes and their association with premature atherosclerosis in patients with rheumatoid arthritis.
     Clin Chim Acta, 412(15): 1332-6. [Abstract] [Full-text]
131. Type I IFN protects against antigen-induced arthritis.
     Eur J Immunol, 41(6): 1687-95. [Abstract] [Full-text]
132. Men's experiences of rheumatoid arthritis: an inductive thematic analysis.
     Musculoskeletal Care, 9(2): 102-12. [Abstract] [Full-text]
133. Guidelines for the management of the foot health problems associated with rheumatoid arthritis.
     Musculoskeletal Care, 9(2): 86-92. [Abstract] [Full-text]
134. Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry.
     Ann Rheum Dis, 70(7): 1216-22. [Abstract] [Full-text]
135. The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy.
     Cytokine, 55(1): 116-21. [Abstract] [Full-text]
136. Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate.
     Ann Rheum Dis, 70(7): 1289-91. [Abstract] [Full-text]
137. Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression.
     Ann Rheum Dis, 70(7): 1292-5. [Abstract] [Full-text]
138. Immune complexome analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis.
     Clin Chem, 57(6): 905-9. [Abstract] [Full-text]
139. Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis.
     Ann Rheum Dis, 70(7): 1296-303. [Abstract] [Full-text]
140. Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis.
     Ann Rheum Dis, 70(7): 1208-15. [Abstract] [Full-text]
141. Longitudinal association between coping and psychological distress in rheumatoid arthritis: a systematic review.
     Ann Rheum Dis, 70(7): 1243-50. [Abstract] [Full-text]
142. Potential association of muscarinic receptor 3 gene variants with primary Sjogren's syndrome.
     Ann Rheum Dis, 70(7): 1327-9. [Abstract] [Full-text]
143. The potential role of VPREB1 gene copy number variation in susceptibility to rheumatoid arthritis.
     Mol Immunol, 48(11): 1338-43. [Abstract] [Full-text]
144. Structural damage in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: traditional views, novel insights gained from TNF blockade, and concepts for the future.
     Arthritis Res Ther, 13: S4. [Abstract] [Full-text]
145. Understanding emerging treatment paradigms in rheumatoid arthritis.
     Arthritis Res Ther, 13: S3. [Abstract] [Full-text]
146. Infliximab: 12 years of experience.
     Arthritis Res Ther, 13: S2. [Abstract] [Full-text]
147. Hip resurfacing for rheumatoid arthritis: independent assessment of 11-year results from an international register.
     Int Orthop, 35(6): 803-8. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.